Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   155,668    

Indirect Shares

   6,673      
Direct Value   $5,222,943    

Indirect Value

   $0      
Total Shares   162,341      
Total Value   $5,222,943      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $996,533 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $996,533
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2023-06-02 40,493 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    180         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-02-29 4 D $81.87 $3,828,732 D/D (46,766) 54,311 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-03-02 4 AS $86.12 $398,120 D/D (4,623) 49,688 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-03-03 4 D $89.57 $214,520 D/D (2,395) 47,293 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-03-15 4 A $0.00 $0 D/D 16,640 63,933 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-04-29 4 A $51.26 $10,355 D/D 202 64,135 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-13 4 D $82.71 $142,427 D/D (1,722) 62,413 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-23 4 AS $87.07 $328,184 D/D (3,769) 58,644 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-27 4 D $89.09 $383,532 D/D (4,305) 54,339 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-31 4 AS $89.35 $1,873,126 D/D (20,841) 50,394 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-31 4 OE $39.06 $659,958 D/D 16,896 71,235 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-06-03 4 D $90.00 $162,090 D/D (1,801) 48,593 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-06-06 4 AS $89.14 $146,992 D/D (1,649) 46,944 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-08-01 4 AS $99.33 $397,320 D/D (4,000) 42,944 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-10-31 4 A $68.44 $10,677 D/D 156 43,100 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-11-09 4 S $90.61 $1,812,206 D/D (20,000) 23,100 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-01-09 4 AS $90.00 $450,000 D/D (5,000) 18,100 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-02-24 4 A $0.00 $0 D/D 12,247 30,347 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-02-28 4 AS $94.00 $2,820,000 D/D (30,000) 30,347 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-02-28 4 OE $63.10 $1,893,000 D/D 30,000 60,347 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-01 4 AS $94.50 $472,500 D/D (5,000) 25,347 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-03 4 D $93.95 $214,488 D/D (2,283) 23,064 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-06 4 AS $93.32 $214,916 D/D (2,303) 20,761 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-15 4 D $92.50 $397,843 D/D (4,301) 16,460 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-16 4 AS $91.96 $182,908 D/D (1,989) 14,471 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-22 4 A $0.00 $0 D/D 12,200 26,671 0 -
  180  Records found
  1   2   3  4   5   6   7   8      
  Page 3 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us